BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4629973)

  • 1. Pharmacology of a halogenated aralkylamine with anorectic properties.
    Macko E; Saunders H; Heil G; Fowler P; Reichard G
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):102-17. PubMed ID: 4629973
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the pharmacologic actions of amphetamine and fenfluramine.
    Yelnosky J; Lawlor RB
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):374-88. PubMed ID: 5460189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies with the new appetite depressant N-(3-chlorpropyl)-1-methyl-2-phenylethylamine hydrochloride (Ro 4-5282)].
    Blum JE
    Arzneimittelforschung; 1969 May; 19(5):748-55. PubMed ID: 5819782
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of phentermine.
    Yelnosky J; Panasevich RE; Borrelli AR; Lawlor RB
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):62-76. PubMed ID: 5353475
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores.
    Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405
    [No Abstract]   [Full Text] [Related]  

  • 6. Some cardiovascular and autonomic effects of fenfluramine hydrochloride.
    Sipes IG; Ziance RJ; Buckley JP
    J Pharmacol Exp Ther; 1971 Jan; 176(1):220-8. PubMed ID: 4398217
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of 2-(ethylamino)-2-(2-thienyl)-cyclohexanone-HCl (CI-634).
    Chen G; Ensor CR; Bohner B
    J Pharmacol Exp Ther; 1969 Jul; 168(1):171-9. PubMed ID: 4978323
    [No Abstract]   [Full Text] [Related]  

  • 8. Anorectic activity of some amphetamine-derivatives with low CNS stimulating potency.
    Gemignani A; Versace P; Cugurra F; Vaccari A
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):88-101. PubMed ID: 4643290
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of Wd 67-2, a new synthetic anorectic agent].
    Dalla Vedova R; D'Alò G
    Boll Chim Farm; 1973 Apr; 112(4):273-82. PubMed ID: 4721650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic study of fenfluramine and its optical isomers].
    Le Douarec JC; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):206-32. PubMed ID: 5941878
    [No Abstract]   [Full Text] [Related]  

  • 11. [On pharmacology of a series of phenylalkylamines].
    Hüller H; Scheler W; Greiner-Leben H; Fermum R; Marx E; Peters R
    Acta Biol Med Ger; 1967; 19(3):463-77. PubMed ID: 5591163
    [No Abstract]   [Full Text] [Related]  

  • 12. CARDIOVASCULAR AND AUTONOMIC EFFECTS OF FENFLURAMINE HYDROCHLORIDE.
    FRANKO BV; HONKOMP LJ; WARD JW
    J Pharm Pharmacol; 1965 Apr; 17():222-6. PubMed ID: 14327709
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacology of derivatives with oxime function: 2-hydroxy-3-methoxy-benzaldoxime].
    Pham-Huu-Chanh ; Chanvattey S; Azum-Gelade MC; Silve-Mamy G
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):443-58. PubMed ID: 4391898
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties.
    Chiba S; Saji Y; Hibino H; Takeo Y; Yui T
    Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenfluramine: study of its central action through its effects on sleep.
    Gagnon MA; Bordeleau JM; Tétreault L
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):74-82. PubMed ID: 4894948
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice.
    Abdallah AH
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):395-402. PubMed ID: 5715411
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of blood pressure during chronic effect of phenylalkylamines].
    Kemper F
    Arzneimittelforschung; 1969 Oct; 19(10):1702-4. PubMed ID: 5395371
    [No Abstract]   [Full Text] [Related]  

  • 18. The possible central stimulant mechanisms of some appetite suppressants.
    Offermeier J; Potgieter B
    S Afr Med J; 1972 Jan; 46(4):72-7. PubMed ID: 5058666
    [No Abstract]   [Full Text] [Related]  

  • 19. Fenfluramine and body temperature.
    Jespersen S; Bonaccorsi A; Garattini S
    J Pharm Pharmacol; 1969 Aug; 21(8):558-9. PubMed ID: 4389729
    [No Abstract]   [Full Text] [Related]  

  • 20. The selectivity of the anorectic effect of satietin. III. The ineffectiveness of satietin on metabolic rate, body temperature and blood pressure.
    Timár J; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):33-9. PubMed ID: 7167421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.